Related Experiment Video

Updated: Feb 9, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

Alena Grebe1, Florian Hoss1, Eicke Latz2,3,4,5

  • 1From the Institute of Innate Immunity, University Hospital Bonn, Germany (A.G., F.H., E.L.).

Circulation Research
|June 9, 2018
PubMed

Insights

Targeting inflammation, specifically interleukin-1 beta, can improve cardiovascular outcomes. The NLRP3 inflammasome pathway is key in atherosclerosis, offering new therapeutic targets for cardiovascular diseases.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Biology

Background:

  • Inflammation drives atherosclerosis, the root cause of cardiovascular diseases.
  • Targeting inflammatory pathways may improve cardiovascular outcomes.
  • The CANTOS trial demonstrated the efficacy of canakinumab, an interleukin-1 beta-neutralizing antibody.

Purpose of the Study:

  • To review the mechanisms of NLRP3 inflammasome activation in atherosclerosis.
  • To discuss the role of IL-1 family cytokines in atherogenesis.
  • To explore therapeutic strategies targeting the NLRP3 inflammasome for cardiovascular diseases.

Main Methods:

  • Review of scientific literature on inflammation, atherosclerosis, and the NLRP3 inflammasome.
  • Analysis of findings from the CANTOS trial.
  • Discussion of molecular mechanisms of inflammasome activation and cytokine production.

Main Results:

  • Interleukin-1 beta and other IL-1 family cytokines are key mediators of vascular inflammation in atherosclerosis.
  • The NLRP3 inflammasome is a central regulator of IL-1 family cytokine production.
  • NLRP3 inflammasome activation is triggered by danger signals in atherosclerotic lesions, promoting disease progression.

Conclusions:

  • The NLRP3 inflammasome is a critical target for managing atherosclerosis.
  • Therapeutic inhibition of the NLRP3 inflammasome pathway holds promise for cardiovascular disease treatment.
  • The CANTOS trial provides strong evidence for targeting IL-1 beta in cardiovascular disease.
Keywords:
atherosclerosiscanakinumabcytokinesinflammasomesinflammation

More Related Videos

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K
Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.4K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
433
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
548
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
460
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
941